| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.002 |